Department of Neurology, Kyushu University, Fukuoka 812-8582, Japan.
Brain Pathol. 2013 Sep;23(5):534-46. doi: 10.1111/bpa.12040. Epub 2013 Mar 1.
We investigated the mechanisms underlying abnormal vascular endothelial growth factor (VEGF) production in amyotrophic lateral sclerosis (ALS). We immunohistochemically studied VEGF, its receptors VEGFR1 and 2, and hypoxia-inducible factor-1α (HIF-1α) in autopsied ALS spinal cords. We also chronologically assessed the expression of HIF-1α, karyopherin β1, karyopherin β-cargo protein complex inhibitors and nuclear pore complex proteins in G93A mutant superoxide dismutase 1 (mSOD1) transgenic mice at presymptomatic, symptomatic and end stages. In ALS patients, compared with controls, HIF-1α immunoreactivity in the cytoplasm of anterior horn cells (AHCs) was significantly increased, while immunoreactivities for VEGF and VEGFRs were significantly decreased. Similar changes in HIF-1α and VEGF levels were observed in mSOD1 transgenic mice. HIF-1α co-localized with karyopherin β1 in the cytoplasm of AHCs and karyopherin β1 co-localized with nucleoporin 62 (Nup62) on the nuclear envelope. From the presymptomatic stage of mSOD1 transgenic mice, karyopherin β1 immunoreactivity in AHC nuclei significantly decreased and morphological irregularities of the Nup62-immunostained nuclear envelope became more pronounced with disease progression. Thus, in AHCs from mSOD1 transgenic mice, transport of cytoplasmic HIF-1α to the nuclear envelope and into the nucleus is impaired from the presymptomatic stage, suggesting that impaired cytoplasmic-nuclear transport of HIF-1α through the nuclear pore might precede motor neuron degeneration.
我们研究了肌萎缩侧索硬化症(ALS)中血管内皮生长因子(VEGF)产生异常的机制。我们通过免疫组织化学方法研究了尸检 ALS 脊髓中的 VEGF、其受体 VEGFR1 和 2 以及缺氧诱导因子-1α(HIF-1α)。我们还在 G93A 突变超氧化物歧化酶 1(mSOD1)转基因小鼠的无症状前、症状期和终末期,按时间顺序评估了 HIF-1α、核孔转运蛋白β1、核孔转运蛋白β-货物蛋白复合物抑制剂和核孔复合体蛋白的表达。在 ALS 患者中,与对照组相比,前角细胞(AHC)细胞质中的 HIF-1α免疫反应性显著增加,而 VEGF 和 VEGFRs 的免疫反应性则显著降低。在 mSOD1 转基因小鼠中也观察到 HIF-1α 和 VEGF 水平的相似变化。HIF-1α与 AHC 细胞质中的核孔转运蛋白β1共定位,核孔转运蛋白β1与核膜上的核孔蛋白 62(Nup62)共定位。从 mSOD1 转基因小鼠的无症状前阶段开始,AHC 核内的核孔转运蛋白β1免疫反应性显著降低,随着疾病的进展,Nup62 免疫染色的核膜的形态不规则性变得更加明显。因此,在 mSOD1 转基因小鼠的 AHC 中,从无症状前阶段开始,细胞质 HIF-1α向核膜和核内的转运就受到了损害,这表明 HIF-1α 通过核孔的细胞质-核转运受损可能先于运动神经元变性。